Profil
Jacqueline Cossmon worked as a Senior Director of Investor Relations at XenoPort, Inc. and as an Investor Relations Contact at Veracyte, Inc. She later worked as a Senior VP of Investor Relations and Communications at Tricida, Inc. from 2018 to 2022.
Anciens postes connus de Jacqueline Cossmon
| Sociétés | Poste | Fin |
|---|---|---|
| TRICIDA, INC. | Investor Relations Contact | 01/01/2022 |
| VERACYTE, INC. | Public Communications Contact | - |
| XENOPORT, INC. | Investor Relations Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| VERACYTE, INC. | Health Technology |
| TRICIDA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
